Scott Randal W.
Director
1 company
Insider Signal Score
45
WeakTrades Analyzed
8
12M Win Rate
42.9%
Avg 3M Return
-0.5%
Avg 12M Return
-16.9%
Scott Randal W. is a Director at BridgeBio Pharma, Inc.. Recent SEC Form 4 filings include 1 buy and 10 sells.
Estimated insider holdings value: $768K based on current market prices.
Holdings by Company
BBIONov 17, 2025
Current Shares11.6K
Value$768.0K
Net Activity-6,000
Bought: 16.0KSold: 22.0K
Transaction History
Showing 7 filings
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 17, 2025 | BBIO Bridgebio Pharma, Inc. | Director | Sale+OE | 10,000 | $66.65 | $666,465.10 | -25.4% | +13.4% | - | |
| Jun 4, 2024 | BBIO Bridgebio Pharma, Inc. | Director | Sell | 2,500 | $30.32 | $75,792.52 | -14.1% | +5.9% | +40.1% | |
| Mar 1, 2024 | BBIO Bridgebio Pharma, Inc. | Director | Sell | 2,500 | $34.00 | $85,000.00 | -27.8% | -19.0% | -2.0% | |
| Dec 18, 2023 | BBIO Bridgebio Pharma, Inc. | Director | Sell | 2,000 | $40.00 | $80,000.00 | -18.2% | -27.7% | -27.6% | |
| Dec 1, 2023 | BBIO Bridgebio Pharma, Inc. | Director | Sell | 2,500 | $29.40 | $73,500.00 | -9.6% | +10.4% | -12.4% | |
| Sep 5, 2023 | BBIO Bridgebio Pharma, Inc. | Director | Sell | 2,500 | $30.00 | $75,000.00 | -15.6% | +7.8% | +3.5% | |
| Feb 17, 2021 | BBIO Bridgebio Pharma, Inc. | Director | Buy | 16,000 | $62.50 | $1,000,000.00 | +320.0% | -13.9% | -87.1% |